|
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 4997-5007.
Prepublished online as a Blood First Edition Paper on March 12, 2008; DOI 10.1182/blood-2007-08-108597.
Previous Article | Next Article 
Submitted August 22, 2007
Accepted February 28, 2008
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype
Richard C. A. Sainson, Douglas A Johnston, Henry C Chu, Matthew T Holderfield, Martin N Nakatsu, Steven P Crampton, Jaeger Davis, Erin Conn, and Christopher C. W. Hughes*
Department of Molecular Biology & Biochemistry, University of California, Irvine, CA, United States
* Corresponding author; email: cchughes{at}uci.edu.
Pathological angiogenesis associated with wound healing often occurs subsequent to an inflammatory response that includes the secretion of cytokines such as Tumor Necrosis Factor (TNF). Controversy exists on the angiogenic actions of TNF, with it being generally pro-angiogenic in vivo, but anti-angiogenic in vitro. We find that whereas continuous administration of TNF in vitro or in vivo inhibits angiogenic sprouting, a 2-3 day pulse stimulates angiogenesis by inducing an endothelial "tip cell" phenotype. TNF induces the known tip cell genes Platelet-Derived Growth Factor B (PDGFB) and Vascular Endothelial Cell Growth Factor Receptor-2 (VEGFR2), while at the same time blocking signaling through VEGFR2, thus delaying the VEGF-driven angiogenic response. Notch signaling regulates tip cell function and we find that TNF also induces the notch ligand jagged-1, through an NF B-dependent mechanism. Enrichment of jagged-1 in tip cells was confirmed by immunofluorescent staining as well as by laser capture microdissection/qRT-PCR of tip cells sprouting in vitro. Thus, in angiogenesis the temporal expression of TNF is critical: it delays angiogenesis initially by blocking signaling through VEGFR2, but in addition by inducing a tip cell phenotype through an NF B-dependent pathway, it concomitantly primes EC for sprouting once the initial inflammatory wave has passed.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Gabrielli, E. V. Avvedimento, and T. Krieg
Scleroderma
N. Engl. J. Med.,
May 7, 2009;
360(19):
1989 - 2003.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Al-Mahmood, S. Colin, N. Farhat, E. Thorin, C. Steverlynck, and S. Chemtob
Potent in Vivo Antiangiogenic Effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an Antisense Oligonucleotide Preventing the Expression of Insulin Receptor Substrate-1
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
496 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. De Smet, I. Segura, K. De Bock, P. J. Hohensinner, and P. Carmeliet
Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2009;
29(5):
639 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|